Synthase Biotech Ltd
2 known investors
Find your way into Synthase Biotech Ltd
Sign up to see every warm intro you have to Synthase Biotech Ltd
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Synthase Biotech Ltd team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Early-stage company commercialising the Aloxsyn® enzyme technology that prevents and repairs lipid oxidation damage in cell membranes, initially applied to livestock fertility (AI and IVF) with broader potential in human fertility and food/beverage shelf life.
Investors · 2
Frequently asked questions
- What does Synthase Biotech Ltd do?
- Early-stage company commercialising the Aloxsyn® enzyme technology that prevents and repairs lipid oxidation damage in cell membranes, initially applied to livestock fertility (AI and IVF) with broader potential in human fertility and food/beverage shelf life.
- Who are Synthase Biotech Ltd's investors?
- Synthase Biotech Ltd's investors include Matū, NZ Growth Capital Partners.
